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induction of DUSP-1 gene expression was mediated by EP2/EP4 re-
ceptors coupled to both the protein kinase A and p38 MAP kinase
pathways. In the dorsal air-pouch mouse model of synovial inﬂammation,
LPS-treatments provoked air pouch edema and signiﬁcant leukocyte
inﬁltration (predominantly neutrophils, CDw17 and monocytes, CD11c)
after 6−24 h, with concomitant increases in TNF-a, Il-1b, MIP-1a, MMP-8,
MMP-9, and MMP-13 levels in the exudates. Pre-treatment (30min) with
1mmol/L of PGE2 or PGE2 mimetics like forskolin/rolipram reduced LPS-
induced leukocyte inﬁltration by 42±5% (mean±SD) while TNF-a, MIP-
1a, MMP-9, and MMP-13 expression levels fell by 67 to 91% on average.
PGE2-dependent suppression of induced leukocyte inﬁltration and MMP-
9/TNF-a expression were abrogated in DUSP-1 null (−/−) mice.
Conclusions: We conclude that PGE2-dependent modulation of molec-
ular and cellular components of the inﬂammatory/proliferative/catabolic
response is mediated, at least in part, by DUSP-1. DUSP-1 may be
a promising drug target for modulating MAPK-dependent proliferative
responses in arthritis, infectious diseases and cancers.
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Purpose: Prostaglandin E2 (PGE2) plays a profound role in the
pathogenic processes of rheumatoid arthritis (RA). Recently, it has been
reported that mitochondrial alterations may contribute to the progression
of RA. In this study, we have investigated the relationship between the
dysfunction of mitochondrial respiratory chain (MRC) and the in vitro
expression of COX-2 in cultured normal human synoviocytes.
Methods: Normal human synoviocytes were isolated from knee synovium
obtained from necropsy from 9 adult cadavers (mean age 43 years). Com-
monly used inhibitors of the MRC were employed to induce mitochondrial
dysfunction. Rotenone (1 and 10mg/ml), 3-nitropropionic acid (0.5, 2 and
10mM), Antimycin A (AA: 5, 10 and 20 mg/ml), Sodium azide (2, 10 and
25mM) and Oligomycin (5, 10 and 25mg/ml) were employed as inhibitor
of the complex I, II, III, IV and V of MRC, respectively. Protein and mRNA
COX-2 expression were analyzed by cytometry and real time PCR. PGE2
levels were evaluated by ELISA. As a positive control, COX-2 expression
was induced by Il-1b (1 ng/ml).
Results: Firstly, only the exposure of synoviocytes to AA and oligomycin
signiﬁcantly increased COX-2 protein expression in a time- and dose
dependent manner. The maximal response was observed at 6 h with
a concentration of 20mg/ml AA and 25mg/ml oligomycin (15.4±3.3 and
28.2±10.8 respectively vs. basal 3.6±0.6, n = 6). At the same time, the
positive control, 1 ng/ml Il-1b, induced a COX-2 protein expression of
45±12.6. When the percentage of cells that expressed COX-2 mRNA
was examined by real time RT-PCR the results obtained at 4 h of stim-
ulation were consistent with those of protein expression (30- and 40-
fold increase for 20mg/ml AA and 25mg/ml oligomycin, respectively, vs.
basal 1). The positive control, 1 ng/ml Il-1b, induced a level of COX-2
mRNA expression of 787-fold increase. When the production of PGE2 at
24 h was assessed similar results were obtained (72±23 and 99±38 for
AA and oligomycin, respectively vs. basal 23±1). Secondly, we tested if
mitochondrial dysfunction induced by AA or oligomycin could modulate
the response induced by Il-1b (1 ng/ml) on COX-2 protein expression.
We found that pre-treatment of synoviocytes with either 5 mg/ml AA or
10mg/ml oligomycin for 30 minutes increases signiﬁcantly the expression
of COX-2 induced by Il-1b (1 ng/ml) at protein levels. The values of COX-2
protein expression were 104.7±38.6 for AA + Il-1b and 96.4±24.4 for
oligomycin + Il-1b vs. 45.0±12.6 for Il-1b (n = 6, p< 0.05).
Conclusions: These results showed that the dysfunction of mitochondrial
respiratory activity induces an inﬂammatory response in synoviocytes
contributing to the chronic inﬂammation of synovial tissue in RA and
aging joint. These data may prove valuable for a better understanding
of the participation of mitochondria in the pathogenesis of RA synovium.
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Purpose:OA is a degenerative joint disease causing loss of joint function,
pain and physical disability. The diarthrodial joint’s diseased tissues
(bone, cartilage, synovium) are sites of production of cytokines (e.g., Il-1b,
TNF-a) and inﬂammatory mediators (e.g., prostaglandins, nitric oxide).
We hypothesize that circulating blood cells, exposed to inﬂammatory
mediators as they perfuse the OA joint, may act as sensors reﬂecting OA
disease activity and/or burden. In the current study we explored whether
PBL from OA patients are primed to produce increased inﬂammatory
mediators compared to PBL from healthy controls.
Methods: We recruited 56 patients with knee OA and 8 age-matched
healthy controls.). QRT-PCR was performed using Applied Biosystems.
PGE2 levels were measured by ELISA (Cayman) from stored plasma
samples.
Results: OA patients produced moderately higher levels of PGE2 than
healthy controls in unstimulated plasma at baseline (p = 0.081). However,
when whole blood from both OA and controls was cultured (24 h) ex
vivo (100 and 94 pg/ml respectively), PGE2 in controls did not change,
while levels in OA patients increased 300% over baseline (p< 0.01). The
increased PGE2 production at 24 hr ex vivo suggested that OA PBLs may
be primed or activated in vivo. We therefore examined mRNA (QPCR)
expression of PBL COX-2, Il-1b and TNFa. Each of these transcripts
were elevated in OA patients (p< 0.02) compared to controls. PBL levels
of Il-1b in OA correlated with TNFa levels (r = 0.43, p = 0.003); increased
COX-2 expression correlated weakly with TNFa expression (r = 0.213,
p< 0.0003). When stratifying these inﬂammatory mediator levels in OA
patients by NSAID use, we observed higher levels of both baseline PGE2
(p< 0.04) and Il-1b mRNA (p=0.04) in NSAID users compared with non-
users. Finally, we asked whether evidence of PBL activation correlated
with radiographic ﬁndings. PBL PGE2 production signiﬁcantly correlated
with semi-quantitative subchondral sclerosis scores (r = 0.37, p< 0.013)
and negatively correlated with osteophyte scores (r = −0.268, p< 0.05).
PGE2 levels trended to correlate with increasing KL scores (p = 0.1).
Relative expression levels of Il-1b but not TNFa moderately correlated
(r = 0.263, p< 0.05) with WOMAC pain score and not with any other x-ray
ﬁndings. (p = 0.4).
Conclusions: OA PBL produce higher levels of PGE2 than do age-
matched controls. PGE2 production is associated with increased PBL
expression of mRNA for COX-2, Il-1b and TNF-a. These data indicate that
PBL are activated by exposure to inﬂammatory stimuli as they circulate
through the diseased synovium and bone in patients with OA. We propose
that activated PBL can serve as biomarkers for disease activity in OA
and may predict patients at risk for disease progression. Whether the
activation of PBL confers a risk of endothelial injury and vascular disease
over time merits additional evaluation.
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Purpose: Innate immune system activation has been implicated in os-
teoarthritis (OA) pathogenesis, but much of what we know about the
synovial inﬂammatory response in this prevalent joint disease is derived
from studies of end-stage patients. In this study, we sought to better
characterize cytokine production in patients with early signs of knee OA,
focusing on the common gamma chain cytokines Il-15 and Il-21, important
mediators linking the innate and adaptive immune response.
Methods: Synovial membrane (SM) and ﬂuid (SF) specimens were col-
lected from patients with degenerative meniscal tears and early cartilage
degeneration undergoing arthroscopic procedures (early OA) and pa-
tients undergoing total knee replacement for end-stage OA. Quantitative
real-time PCR was used to compare expression of SM cytokines and
cell lineage-speciﬁc markers. SF cytokine and matrix-metalloproteinase
(MMP-1 and MMP-3) levels (proteases implicated in cartilage extracellular
matrix remodeling) were quantiﬁed by ELISA. Transcript and protein
levels were compared in early and end-stage specimens, using the
